Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/17124595

Download in:

View as

General Info

PMID
17124595